Mr. Aziz is consultant colorectal surgeon at The Christie, one of Europe's largest comprehensive cancer hospitals. He is the clinical lead for colorectal surgery at The Colorectal & Peritoneal Oncology Centre (CPOC), and specialises in complex minimally invasive (keyhole) and open surgical techniques to treat early, advanced, and recurrent tumours of the appendix, colon, rectum, and anus, including those that have spread to the lining of the abdomen (peritoneum), for which he performs cytoreductive surgery (CRS) with hyperthermic intra-peritoneal chemotherapy (HIPEC). Over 160 CRS/HIPEC procedures are carried out at The Christie CPOC each year. He is also a specialist in retroperitoneal sarcomas, is the endoscopy lead for the trust, is a national laparoscopic colorectal surgery trainer.
Mr Aziz has developed evidence synthesis techniques to better guide healthcare decision-making and published over 100 peer-reviewed research papers, some of which have been used to guide institutions such as the UK National Institute of Clinical Excellence (NICE). He was a member of the 2007 ‘Healthcare for London-A Framework for Action’ team reviewing the capital’s healthcare needs and has an interest in translating biomedical research into new technologies for patient benefit. to date he has obtained grants from Innovate UK, Medical Research Council, Technology Strategy Board, and National Institute for Healthcare Research. He is a cofounder of Smart Surgical Appliances Ltd, a medical device company developing sensor-enabled technologies to increase the adoption of minimally invasive surgery. He is the UK primary investigator for a 5-year CRUK accelerator award to identify biomarkers and develop treatment options for patients with pseudomyxoma peritonei and a co-investigator on a 3-year NIHR HTA grant evaluating the cost-effectiveness of CRS/HIPEC in treatment of ovarian, colorectal, and gastric adenocarcinoma.